Endo launches authorized Proventil generic
Endo International announced today that its operating company, Par Pharmaceutical, has begun shipping an authorized generic version of Merck’s Proventil (albuterol sulfate inhalation aerosol), in a 120mcg dosage strength.
Endo’s subsidiary, Endo Procurement Operations, recently entered into an exclusive U.S. supply and distribution agreement with a subsidiary of Merck, allowing Par to launch and distribute an authorized generic of the product.
“We are very pleased to add albuterol sulfate to Par’s portfolio and to be able to offer the authorized generic of the product to patients,” Par president Tony Pera said. “Par has partnered with Merck several times to bring an authorized generic product to market and we are proud to be a reliable, quality supplier.”
No comments found